3648 results for «555»
3648 results
The Navitor with FlexNav TAVI system: when smooth implantability allows to optimise TAVI outcomes
21 Nov 2021 – From PCR London Valves 2021
In this session from the PCR London Valves 2021 Congress, find out more about the new Navitor valve and FlexNav delivery system, discover how to achieve favourable patient outcomes, and learn how choosing a device can impact patient lifetime management.
...Not just TAVI
21 Nov 2021 – From PCR London Valves 2021
Browse this page to discover simultaneous TAVR and tricuspid valve-in-valve, combined percutaneous valve-in-valve TAVI and mitral repair in degenerated freestyle full root, paravalvular leak post TAVR causing hemolysis treated with balloon dilatation and PVL closure, and much more!
Best cases session
21 Nov 2021 – From PCR London Valves 2021
This session from the PCR London Valves 2021 Congress compiles a series of the best cases submitted during this edition. Discover, among others, cases of severe aortic valve and ostial coronary disease, as well as transcatheter valvular lithotripsy in cases with severely calcific aortic or mitral...
Best cases and research unveiled at AICT-Asia PCR 2021
08 Oct 2021 – From AICT-AsiaPCR 2021
Watch this session to discover some of the best cases and research unveiled at AICT-Asia PCR 2021: positive remodelling of coronary arteries on CT coronary angiogram, investigation of heavy metals in coronary artery tissues in autopsy cases, DEB vs. DES in the main vessel for treatment of...
A large-scale, randomized trial of orbital atherectomy vs. conventional balloon angioplasty in severely calcified coronary arteries prior to DES implantation (ECLIPSE)
30 Oct 2024
Nicola Ryan provides her take on the ECLIPSE trial presented by Ajay J. Kirtane at TCT 2024 in Washington.
Author
GLORIOUS - Efficacy of restrictive versus liberal oxygenation or Exenatide in patients undergoing coronary artery bypass grafting or aortic valve replacement – a randomised clinical trial
21 Nov 2024
Edoardo Zancanaro provides his take on the GLORIOUS trial presented by Sebastian Wiberg at AHA 2024 in Chicago.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Transcatheter edge-to-edge repair in patients with severe mitral regurgitation and cardiogenic shock: Insights from the TVT Registry
17 Sep 2022
Mirvat Alasnag provides her take on the TEER Shock study which was presented at TCT 2022 by Mohamad A. Alkhouli.
Author
